PSMA5 |
PSMA5: Proteasome subunit alpha type-5 |
PSMB3 |
PSMB3: Proteasome subunit beta type-3 |
111.000 |
Evidence |
O
|
FXR1 |
FXR1: Fragile X mental retardation syndrome-related protein 1 |
FXR2 |
FXR2, FMR1L2: Fragile X mental retardation syndrome-related protein 2 |
110.000 |
Evidence |
O
|
CD3E |
CD3E, T3E: T-cell surface glycoprotein CD3 epsilon chain precursor |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
109.000 |
Evidence |
O
|
JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
107.000 |
Evidence |
O
|
TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
JAK1 |
|
106.000 |
Evidence |
O
|
POLR2D |
POLR2D: DNA-directed RNA polymerase II subunit RPB4 |
POLR2A |
POLR2A: Uncharacterized protein POLR2A |
106.000 |
Evidence |
O
|
POLR2D |
POLR2D: DNA-directed RNA polymerase II subunit RPB4 |
POLR2B |
POLR2B: DNA-directed RNA polymerase II subunit RPB2 |
106.000 |
Evidence |
O
|
PDHA1 |
PDHA1, PHE1A: Pyruvate dehydrogenase E1 component subunit alpha, somatic form, m |
DLAT |
Dihydrolipoamide S-acetyltransferase (Fragment) |
106.000 |
Evidence |
O
|
EIF2S2 |
EIF2S2, EIF2B: Eukaryotic translation initiation factor 2 subunit 2 |
EIF2B5 |
EIF2B5, EIF2BE: Translation initiation factor eIF-2B subunit epsilon |
105.000 |
Evidence |
O
|
ACTG1 |
ACTB: Actin, cytoplasmic 1 |
CFL1 |
CFL1, CFL: Cofilin-1 |
105.000 |
Evidence |
O
|
POLR1C |
POLR1C, POLR1E: DNA-directed RNA polymerases I and III subunit RPAC1 |
POLR2H |
POLR2H: DNA-directed RNA polymerases I, II, and III subunit RPABC3 |
105.000 |
Evidence |
O
|
JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
105.000 |
Evidence |
O
|
CRYAA |
CRYAA, CRYA1, HSPB4: Alpha-crystallin A chain |
CRYBB2 |
CRYBB2, CRYB2, CRYB2A: Beta-crystallin B2 |
105.000 |
Evidence |
O
|
CRYAB |
CRYAB, CRYA2: Alpha-crystallin B chain |
CRYGC |
CRYGC, CRYG3: Gamma-crystallin C |
105.000 |
Evidence |
O
|
PRSS1 |
PRSS1, TRP1, TRY1, TRYP1: Trypsin-1 precursor |
SERPINF2 |
SERPINF2, AAP, PLI: Alpha-2-antiplasmin precursor |
102.000 |
Evidence |
O
|
CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
101.000 |
Evidence |
O
|
PSMD12 |
PSMD12: 26S proteasome non-ATPase regulatory subunit 12 |
PSMD3 |
PSMD3: 26S proteasome non-ATPase regulatory subunit 3 |
100.000 |
Evidence |
O
|
PSMD12 |
PSMD12: 26S proteasome non-ATPase regulatory subunit 12 |
PSMD13 |
PSMD13: 26S proteasome non-ATPase regulatory subunit 13 |
100.000 |
Evidence |
O
|
COPZ1 |
COPZ1, COPZ, CGI-120, HSPC181: Coatomer subunit zeta-1 |
COPG |
|
100.000 |
Evidence |
O
|
ERCC5 |
ERCC5, ERCM2, XPG, XPGC: DNA-repair protein complementing XP-G cells |
GTF2H1 |
GTF2H1, BTF2: TFIIH basal transcription factor complex p62 subunit |
100.000 |
Evidence |
O
|
MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
100.000 |
Evidence |
O
|
VTI1A |
VTI1A: Vesicle transport through interaction with t-SNAREs homolog 1A |
VPS45A |
VPS45A, VPS45, VPS45B: Vacuolar protein sorting-associated protein 45 |
99.180 |
Evidence |
O
|
DLL1 |
DLL1, UNQ146/PRO172: Delta-like protein 1 precursor |
NOTCH2 |
NOTCH2: Neurogenic locus notch homolog protein 2 precursor |
98.7 |
Evidence |
O
|
HCN1 |
HCN1, BCNG1: Potassium/sodium hyperpolarization-activated cyclic nucleotide-gate |
HCN2 |
HCN2, BCNG2: Potassium/sodium hyperpolarization-activated cyclic nucleotide-gate |
98.7 |
Evidence |
O
|
GDI2 |
GDI2, RABGDIB: Rab GDP dissociation inhibitor beta |
RAB8A |
RAB8A: RAB8A protein |
98.610 |
Evidence |
O
|